SHM's Perioperative/Co-Management SIG Journal Club: November 23, 2020
We are thrilled to have Dr. Ashish Khanna present his PRODIGY Study and Postop Respiratory Depression.
The presentation will be followed by an interactive Q&A session and discussion.
The PRODIGY trial (Prediction of Opioid Induced Respiratory Depression in Patients Monitored By Capnography) was conducted across North America, Europe and Asia and enrolled adult patients who received parenteral opioids while being monitored with continuous oximetry and capnography ( HR,SpO2,RR,EtCO2 and Integrated Pulmonary Index). A total of 16 sites across the world were involved in the trial, and included 1335 patients in the final analysis. Of note, continuous monitoring was blinded and alarms were silenced from bedside providers who continued with traditional spot check monitoring per hospital protocol. All the continuous monitoring data was sent to an independent clinical event committee that adjudicated waveforms and separated true episodes from artifacts.
The following relationships have been reported for this activity:
Dr. Ashish Khanna
Dr. Khanna reports a consulting fee from Medtronic and Edwards Lifesciences.
Steven L Cohn, MD, MACP, SFHM
Dr. Cohn reports honoraria from Janssen and Portola; royalties from UpToDate, McGraw Hill, and Springer; and stock holdings with GlaxoSmithKline, Merck & Co, Pfizer, and Portola.
Kurt Pfeifer, MD, FACP, SFHM
Dr. Pfeifer reports having no relevant financial or advisory relationships with corporate organizations relevant to this activity.
SHM CONFLICT OF INTEREST DISCLOSURE POLICY
In accordance with the ACCME Standards for Commercial Support, SHM requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. SHM resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. All relevant financial relationships shall be disclosed to participants prior to the start of the activity.
Furthermore, SHM seeks to verify that all scientific research referred to, reported, or used in a continuing medical education (CME) activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SHM is committed to providing its learners with high-quality CME activities that promote improvements in healthcare and not those of a commercial interest.
The Society of Hospital Medicine designates this live activity, for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in this activity
The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provider continuing medical education for physicians.
The Society of Hospital Medicine (SHM) funds all of the costs of online webinar; no fee is required to attend. Exhibitors may be present. The exhibitors have no role in developing the meeting content, which was developed solely by the speaker invited by this SHM SIG.
SHM is dedicated to promoting the highest quality care for all hospitalized patients. SHM is committed to promoting excellence in the practice of hospital medicine through education, advocacy and research.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-physician